David is currently the Vice President of Large Molecule Technology and a member of the PGS Global Technology & Engineering leadership team.  In this role, David and his team are responsible for providing technical leadership and support for all new and marketed vaccine/biological products.  This scope includes 2^nd generation process development, technology transfer, supply robustness, new technology development, and clinical supply manufacturing of Gene Therapy products in the Gene Therapy Stage 1 facility.

David joined Pfizer in 2004 as a member of the clinical manufacturing team at the Andover, Massachusetts, site.  He has held various technical and leadership roles in large molecule process and technology development, scale-up, and clinical and commercial manufacturing.  Prior to joining PGS in 2018, he was a member of the Worldwide Research, Development and Medical (WRDM) Bioprocess R&D Leadership Team, accountable for Pilot Plant operations and iSkid technical development.

David received a BS from Worcester Polytechnic Institute and an MS from Tufts University.

David lives in Massachusetts with his wife and two children.